Neurogene
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 |
|---|---|---|
Revenue | $925 | $0 |
Gross Profit | 108 | -825 |
EBITDA | -19,317 | -17,954 |
EBIT | -20,134 | -18,779 |
Net Income | -18,492 | -16,921 |
Net Change In Cash | 925 | 0 |
Free Cash Flow | -16,083 | -21,715 |
Cash | 111,032 | 150,140 |
Basic Shares | 16,941 | 16,903 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -3,262 | -3,196 | -2,277 |
EBITDA | -49,363 | -51,987 | -49,570 |
EBIT | -52,625 | -55,183 | -51,847 |
Net Income | -36,317 | -55,189 | -50,517 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -51,743 | -55,054 | -64,769 |
Cash | 148,210 | 82,021 | 70,544 |
Basic Shares | 12,823 | 12,823 | 55,041 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$1.09 |
2024-03-31 | -$1 |
2023-12-31 | -$1.51 |
2023-09-30 | -$0.40 |
